FDA clears CAD between Fischer Imaging and R2 Technology
The FDA has given the go-ahead to Fischer Imaging Corp. and R2 Technology Inc. to integrate their respective technologies.
The ruling allows Fischer Imaging to integrate its SenoScan digital mammography system with R2's computer-aided detection (CAD) technology. In addition, R2 Technology's ImageChecker DM analog system -- which received FDA clearance in September -- also will support CAD analysis of digital images acquired on the SenoScan system.
The ImageChecker DM System will be distributed directly by Fischer and R2.
The ruling allows Fischer Imaging to integrate its SenoScan digital mammography system with R2's computer-aided detection (CAD) technology. In addition, R2 Technology's ImageChecker DM analog system -- which received FDA clearance in September -- also will support CAD analysis of digital images acquired on the SenoScan system.
The ImageChecker DM System will be distributed directly by Fischer and R2.